Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic issues relating to access to medications.

N B Shulman

    Cardiovascular Clinics
    |January 1, 1991
    PubMed
    Summary
    This summary is machine-generated.

    Millions of uninsured, low-income workers cannot afford essential prescription drugs for conditions like hypertension. This leads to worsened health and increased healthcare costs, highlighting the need for accessible medication programs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Blood pressure and end-stage renal disease in men.

    The New England journal of medicine·1996
    Same author

    Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent.

    Circulation·1992
    Same author

    Impact of cost problems on morbidity in a hypertensive population.

    American journal of preventive medicine·1991
    Same author

    Renal vascular disease in African-Americans and other racial minorities.

    Circulation·1991
    Same author

    Urgent hypertension.

    Archives of internal medicine·1989
    Same author

    Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

    Hypertension (Dallas, Tex. : 1979)·1989

    Area of Science:

    • Health Economics
    • Public Health
    • Pharmacoeconomics

    Background:

    • Millions of uninsured, low-income individuals face financial barriers to accessing prescription drugs.
    • Hypertension disproportionately affects low-income populations, exacerbating health disparities.
    • Current programs are insufficient to address the medication access gap for the medically indigent.

    Purpose of the Study:

    • To highlight the financial challenges faced by low-income workers in obtaining essential medications.
    • To underscore the link between income, hypertension, and the risk of costly complications.
    • To advocate for a collaborative initiative to improve medication accessibility.

    Main Methods:

    • Analysis of the correlation between income levels and the prevalence of hypertension.

    Related Experiment Videos

  • Assessment of the economic impact of medication non-adherence in low-income populations.
  • Review of existing healthcare and pharmaceutical assistance programs.

    • Main Results:

    • Low-income workers, particularly Black individuals, are financially unable to afford crucial prescription drugs.
    • Inadequate access to medication leads to wasted diagnostic funds and increased likelihood of severe, costly health complications.
    • Inverse correlation between income and blood pressure indicates highest susceptibility to complications among those least able to afford treatment.

    Conclusions:

    • A joint federal government and pharmaceutical industry initiative is necessary to fund programs for medication accessibility.
    • Addressing medication affordability for the medically indigent is crucial for preventing complications and reducing overall healthcare expenditure.
    • Improved access to antihypertensive medications can mitigate severe health outcomes and associated economic burdens.